🇺🇸 triamcinolone XRG5029 in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised triamcinolone XRG5029 on 11 July 1991

Marketing authorisation

FDA — authorised 11 July 1991

Application: NDA019798
Marketing authorisation holder: CHATTEM SANOFI
Local brand name: NASACORT
Indication: AEROSOL, METERED — NASAL
Status: approved

Read official source →

Frequently asked questions

Is triamcinolone XRG5029 approved in United States?

Yes. FDA authorised it on 11 July 1991.

Who is the marketing authorisation holder for triamcinolone XRG5029 in United States?

CHATTEM SANOFI holds the US marketing authorisation.